title: Effect of interleukin-1beta and dehydroepiandrosterone on the expression of lumican and fibromodulin in fibroblast-like synovial cells of the human temporomandibular joint.
abstract: Several epidemiological studies have reported that temporomandibular disorders (TMDs) are more prevalent in women than in men. It has recently been proposed that sex hormones such as estrogen, testosterone and dehydroepiandrosterone (DHEA) are involved with the pathogenesis of TMDs. Although studies have investigated the relationship between estrogen and testosterone and the restoration of TMDs, the relationship between DHEA and TMDs is unknown. The synovial tissue of the temporomandibular joint (TMJ) is made up of connective tissue with an extracellular matrix (ECM) composed of collagen and proteoglycan. One proteoglycan family, comprised of small leucine-rich repeat proteoglycans (SLRPs), was found to be involved in collagen fibril formation and interaction. In recent years, the participation of SLRPs such as lumican and fibromodulin in the internal derangement of TMJ has been suggested. Although these SLRPs may contribute to the restoration of the synovium, their effect is still unclear. The purpose of this study was to investigate the effect of DHEA, a sex hormone, on the expression of lumican and fibromodulin in human temporomandibular specimens and in cultured human TMJ fibroblast-like synovial cells in the presence or absence of the pro-inflammatory cytokine interleukin-1beta (IL-1beta). In the in vivo study, both normal and osteoarthritic (OA) human temporomandibular synovial tissues were immunohistochemically examined. In the in vitro study, five fibroblast-like synoviocyte (FLS) cell lines were established from human TMJ synovial tissue of patients with osteoarthritis. The subcultured cells were then incubated for 3, 6, 12 or 24 h with/without IL-1beta (1 ng/mL) in the presence or absence of DHEA (10 μM). The gene expression of lumican and fibromodulin was examined using the real-time polymerase chain reaction (PCR) and their protein expression was examined using immunofluorescent staining. We demonstrated that the expression of lumican significantly differs from that of fibromodulin in synovial tissue in OA and furthermore, that IL-1beta induced a significant increase in lumican mRNA and immunofluorescent staining in FLS compared to cells without IL-1beta. DHEA plus IL-1beta induced a significant increase in fibromodulin, but not in lumican mRNA, compared to DHEA alone, IL-1beta alone and in the absence of DHEA and IL-1beta. In immunofluorescent staining, weaker fibromodulin staining of FLS cells was observed in cells cultured in the absence of both DHEA and IL-1beta compared to fibromodulin staining of cells cultured with DHEA alone, with DHEA plus IL-1beta, or with IL-1beta alone. These results indicate that DHEA may have a protective effect on synovial tissue in TMJ by enhancing fibromodulin formation after IL-1beta induced inflammation. DHEA enhancement of fibromodulin expression may also exert a protective effect against the hyperplasia of fibrous tissue that TGF-beta1 induces. In addition lumican and fibromodulin are differentially expressed under different cell stimulation conditions and lumican and fibromodulin may promote regeneration of the TMJ after degeneration and deformation induced by IL-1beta.
authors.affiliation: Wakayama Medical University. k-okamo@wakayama-med.ac.jp.
authors.forename: K
authors.initials: K
authors.lastname: Okamoto
authors.forename: N
authors.initials: N
authors.lastname: Kiga
authors.forename: Y
authors.initials: Y
authors.lastname: Shinohara
authors.forename: I
authors.initials: I
authors.lastname: Tojyo
authors.forename: S
authors.initials: S
authors.lastname: Fujita
mesh_terms: D000276:Adjuvants, Immunologic / Q000494:pharmacology; D000328:Adult; D000368:Aged; D002478:Cells, Cultured; D011508:Chondroitin Sulfate Proteoglycans / Q000235:genetics*; D003687:Dehydroepiandrosterone / Q000494:pharmacology*; D016326:Extracellular Matrix Proteins / Q000235:genetics*; D005260:Female; D005347:Fibroblasts / Q000187:drug effects*; D000071235:Fibromodulin; D005786:Gene Expression Regulation / Q000187:drug effects*; D006801:Humans; D007150:Immunohistochemistry; D053583:Interleukin-1beta / Q000494:pharmacology*; D007632:Keratan Sulfate / Q000235:genetics*; D000071234:Lumican; D008297:Male; D008875:Middle Aged; D010003:Osteoarthritis / Q000503:physiopathology; D011509:Proteoglycans / Q000235:genetics*; D060888:Real-Time Polymerase Chain Reaction; D013583:Synovial Membrane / Q000166:cytology*; D013704:Temporomandibular Joint / Q000166:cytology
chemical_list: D000276:Adjuvants, Immunologic; D011508:Chondroitin Sulfate Proteoglycans; D016326:Extracellular Matrix Proteins; C000604330:FMOD protein, human; D053583:Interleukin-1beta; C000604306:LUM protein, human; D000071234:Lumican; D011509:Proteoglycans; D000071235:Fibromodulin; D003687:Dehydroepiandrosterone; D007632:Keratan Sulfate
references.citation: Am J Pathol. 2010 Feb;176(2):812-26
references.pmid: 20035055
references.citation: Scand J Med Sci Sports. 2009 Aug;19(4):536-46
references.pmid: 19422643
references.citation: Mol Biol Rep. 2011 Jun;38(5):3569-72
references.pmid: 21104136
references.citation: Wound Repair Regen. 2011 May-Jun;19(3):368-78
references.pmid: 21518082
references.citation: Arthritis Rheum. 2011 Jul;63(7):1888-97
references.pmid: 21391199
references.citation: Eur J Histochem. 2011;55(2):e11
references.pmid: 22073367
references.citation: J Burn Care Res. 2012 Mar-Apr;33(2):218-27
references.pmid: 22079916
references.citation: J Steroid Biochem Mol Biol. 2013 Mar;134:15-22
references.pmid: 23085002
references.citation: Br J Oral Maxillofac Surg. 2013 Jan;51(1):58-62
references.pmid: 22465223
references.citation: Eur J Histochem. 2013;57(2):e12
references.pmid: 23807291
references.citation: J Dent Res. 2013 Oct;92(10):918-24
references.pmid: 23934157
references.citation: Adv Exp Med Biol. 2014;802:49-58
references.pmid: 24443020
references.citation: J Biol Chem. 2000 Jan 28;275(4):2607-12
references.pmid: 10644720
references.citation: Am J Pathol. 2000 Aug;157(2):423-33
references.pmid: 10934147
references.citation: Matrix Biol. 2002 Jun;21(4):361-7
references.pmid: 12128073
references.citation: Osteoarthritis Cartilage. 2002 Oct;10(10):751-7
references.pmid: 12359160
references.citation: J Prosthet Dent. 1985 Mar;53(3):415-9
references.pmid: 3857339
references.citation: FASEB J. 1992 Jun;6(9):2639-45
references.pmid: 1612287
references.citation: J Biol Chem. 1993 Jun 5;268(16):11874-80
references.pmid: 8099356
references.citation: J Oral Maxillofac Surg. 1994 Sep;52(9):913-7; discussion 918
references.pmid: 8064453
references.citation: J Craniomaxillofac Surg. 1995 Apr;23(2):75-80
references.pmid: 7790511
references.citation: Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997 Mar;83(3):373-86
references.pmid: 9084202
references.citation: Spine (Phila Pa 1976). 1999 Sep 1;24(17):1765-71
references.pmid: 10488504
references.citation: J Endocrinol. 2005 Nov;187(2):169-96
references.pmid: 16293766
references.citation: Arthritis Res Ther. 2006;8(1):R26
references.pmid: 16507124
references.citation: Rheumatol Int. 2006 Nov;27(1):79-85
references.pmid: 17033834
references.citation: J Mol Med (Berl). 2007 May;85(5):481-96
references.pmid: 17219096
references.citation: J Dermatol Sci. 2007 Sep;47(3):217-26
references.pmid: 17601707
references.citation: Eur Spine J. 2007 Dec;16(12):2193-205
references.pmid: 17899219
references.citation: Biochem Biophys Res Commun. 2008 Jul 4;371(3):420-4
references.pmid: 18448071
references.citation: Int J Mol Med. 2008 Jun;21(6):785-90
references.pmid: 18506373
references.citation: Osteoarthritis Cartilage. 2008 Jul;16(7):749-55
references.pmid: 18164633
references.citation: J Biol Chem. 2008 Aug 1;283(31):21305-9
references.pmid: 18463092
references.citation: Br J Dermatol. 2010 Dec;163(6):1174-80
references.pmid: 20738297